ENDPOINTS

Calculating healthcare's real costs

As you probably know by now, my ears perk up when I hear of a new way to vet the...

Axsome reports Phase 3 win for Sunosi in adults with ADHD

Axsome Therapeutics said the lower dose of its sleep disorder drug Sunosi met th...

GSK scores FDA approval for new UTI antibiotic

GSK won approval on Wednesday for a new type of oral antibiotic to treat uncompl...

Exclusive: Anti-aging mRNA therapy biotech acquires Har...

Turn Biotechnologies, a startup developing mRNA therapies to wind back the clock...

WuXi Biologics’ licensing deals help offset Biosecure t...

WuXi Biologics attributed a 32.5% increase in North American revenue last year t...

Kezar toplines small Phase 2a dataset in autoimmune liv...

Kezar reported new data Tuesday morning from a small Phase 2a study in autoimmun...

Cassava ends work on Alzheimer's drug; Alumis gets $40M...

Plus, news about Relmada Therapeutics and Mural Oncology: Cassava Sciences f...

Ophthalmology startup Character Biosciences gets $93M f...

Seven years into its existence, Character Biosciences is ready to enter the clin...

GSK to research whether shingles vaccine can cut dement...

GSK is teaming up with a pair of UK-based research bodies to conduct a “real wor...

GSK to research link between Shingrix and dementia risk...

GSK is teaming up with a pair of UK-based research bodies to conduct a “real wor...

Merck and Hengrui strike $2B deal for Lipoprotein(a) drug

Merck has struck a licensing deal for a cardiovascular drug with Jiangsu Hengrui...

Hillstar Bio raises $67M for immunology drugs

The flurry of immunology biotech launches continues. Boston-based Hillstar B...

Trump taps acting CDC chief Susan Monarez for permanent...

President Donald Trump has nominated acting CDC director Susan Monarez to lead t...

Trump pharma tariffs: Details on impact and timing

President Donald Trump reiterated his plans to “at some point" put tariffs on ph...

AbbVie files suit against Genmab subsidiary ProfoundBio

AbbVie has accused a Genmab subsidiary of stealing trade secrets to build a pote...

FDA's biologics chief stresses need for vaccine transmi...

Incorporating disease transmission data into vaccine trial designs could add to ...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.